Search Within

Sloan Kettering Institute Faculty

Formats
  1. Journal Article (10886)
  2. Meeting Abstract (3786)
  3. Book Section (323)
  4. Review (252)
  5. Conference Paper (207)
  6. Editorial (149)
  7. Research Letter (43)
  8. Book Whole (34)
  9. Miscellaneous (21)
  10. Correspondence (17)
  11. Guidelines (6)
Groups
  1. GSK Faculty (11541)
  2. Molecular Pharmacology and Chemistry Program Faculty (7510)
  3. Department of Medicine (4941)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (4526)
  5. Sloan Kettering Institute Postdocs (3537)
  6. Center for Hematologic Malignancies (3363)

More Groups

People
  1. Murray Brennan (1059)
  2. Steven Larson (959)
  3. Richard O'Reilly (748)
  4. Peter Scardino (671)
  5. Marcel Van Den Brink (618)
  6. Michel Sadelain (586)

More People

Years
  1. 2025 (178)
  2. 2024 (327)
  3. 2023 (367)
  4. 2022 (431)
  5. 2021 (455)
  6. 2020 (475)

More Years

Publications
  1. Blood (1057)
  2. Cancer Research (580)
  3. Journal of Clinical Oncology (392)
  4. Journal of Nuclear Medicine (387)
  5. Journal of Biological Chemistry (370)
  6. Proceedings of the National Academy of Sciences of the United States of America (369)

More Publications

Publishers
  1. Nature Publishing Group (1508)
  2. Elsevier Inc. (1399)
  3. American Association for Cancer Research (1174)
  4. American Society of Hematology (1075)
  5. Cell Press (1025)
  6. Wiley Blackwell (611)

More Publishers

Results (15724)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combined genetic ablation of CD54 and CD58 in car engineered cytotoxic lymphocytes effectively averts allogeneic immune cell rejection
    Meeting Abstract

    Hammer, Q.; Perica, K.; Mbofung, R. M.; van Ooijen, H.; Varady, E.; Jelcic, M.; Pan, Y.; Momayyezi, P.; Groff, B.; Abujarour, R.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Impact of epichaperome inhibitor PU-H71 on anti-tumor T cell responses and its implications for immune and cellular therapy
    Meeting Abstract

    Martinet, J.; Sugita, M.; Alhomoud, M.; Abad, C.; Chiosis, G.; Roboz, G. J.; Boyer, O.; Guzman, M. L.
    Blood (2022)

    Fulltext@MSK | Save
  • RAF-Independent MEK mutations drive histiocytic neoplasms in vivo and are sensitive to single-agent ERK inhibition in patients
    Meeting Abstract

    Durham, B. H.; Singer, M. E.; Benbarche, S.; Erickson, C.; Rahman, J.; Solit, D. B.; Witkowski, M.; Rosen, N.; Abdel-Wahab, O.; Diamond, E. L.
    Blood (2022)

    Fulltext@MSK | Save
  • Target densities in malignant and normal cells determine CAR T cell efficacy and off-target hematotoxicity
    Meeting Abstract

    Haubner, S.; Mansilla-Soto, J.; Nataraj, S.; Kogel, F.; Chang, Q.; De Stanchina, E.; Fraser, K.; Park, J. H.; Wang, X.; Rivière, I.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Overcoming heterogeneity in AML with a novel or-gated HITCAR-1XX platform
    Meeting Abstract

    Haubner, S.; Mansilla-Soto, J.; Garcia Angus, A.; Chang, Q.; De Stanchina, E.; Sadelain, M.
    Blood (2022)

    Fulltext@MSK | Save
  • Inflammatory biomarker clusters are predictive of response and toxicity in large B-cell lymphoma treated with CD19 CAR-T cell therapy
    Meeting Abstract

    Raj, S.; Perales, M. A.; Fein, J. A.; Tomas, A. A.; Batlevi, C. L.; De Lapuerta, M. C.; Dahi, P. B.; Danylesko, I.; Fried, S.; Funnell, T.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1XX CAR T cells in adult patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Rivière, I.; Sikder, D. S.; Senechal, B.; Wang, X.; Bermudez, V. P.; Cathcart, E. R.; Liotta, K.; Joseph, J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Dual IKZF2, and CK1α degrader targets acute myeloid leukemia cells
    Meeting Abstract

    Park, S. M.; Miyamoto, D.; Han, G.; Chan, M.; Curnutt, N.; Tran, N.; Velleca, A.; Kim, J. H.; Schurer, A.; Chang, K.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • New York Stem Cell Foundation Robertson investigators
    Editorial

    McKinley, K. L.; van Boxtel, R.; Finley, L. W. S.; Peña, C. J.; Nowakowski, T. J.
    Cell Stem Cell (2022)

    Fulltext@MSK | Save
  • (89)Z-immuno-PET guided preclinical development of targeted therapies: Demonstrating utility by evaluating fusion proteins in vivo
    Meeting Abstract

    Herrero Alvarez, N.; Lewis, J.; Molvi, Z.; O'Reilly, R.; Nyakatura, E.; Balderes, P.; Viray, T.
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save